Merck's Trading Volume Surges 30.42% to 16.63 Billion, Ranks 30th in Market Activity

On April 17, 2025, Merck's trading volume reached 16.63 billion, marking a 30.42% increase from the previous day, ranking 30th in the day's stock market activity. Merck's stock price rose by 2.01%.

Merck has announced that it will be conducting a clinical trial for its new drug, which is designed to treat a rare form of cancer. The trial will involve 500 patients and is expected to last for two years. The company has stated that the results of the trial will be crucial in determining the drug's efficacy and safety.

Merck has also announced that it will be expanding its manufacturing capabilities in order to meet the growing demand for its products. The company has stated that it will be investing $500 million in new facilities and equipment, which will create 1,000 new jobs.

Merck has also announced that it will be acquiring a smaller biotech company, which specializes in the development of new cancer treatments. The acquisition is expected to be completed by the end of the year, and the company has stated that it will be using the acquired company's technology to develop new drugs.